相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
Kristine R. Crews et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches
Gaelle Magliocco et al.
CLINICAL PHARMACOKINETICS (2019)
Pharmacogenetic Information in Clinical Guidelines: The European Perspective
Jesse J. Swen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Pharmacogenomics, a novel section in the European Journal of Human Genetics
Henk-Jan Guchelaar
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
PharmGKB summary: oxycodone pathway, pharmacokinetics
Rachel Huddart et al.
PHARMACOGENETICS AND GENOMICS (2018)
Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group
P. C. D. Bank et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Analgesic Plasma Concentrations of Oxycodone After Surgery for Breast CancerWhich Factors Matter?
Kristiina Cajanus et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects
Y. Zhou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
A Case of Respiratory Depression in a Child With Ultrarapid CYP2D6 Metabolism After Tramadol
Gilles Orliaguet et al.
PEDIATRICS (2015)
The pharmacogenetics of codeine pain relief in the postpartum period
M. Baber et al.
PHARMACOGENOMICS JOURNAL (2015)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
K. R. Crews et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
PharmGKB summary: tramadol pathway
Li Gong et al.
PHARMACOGENETICS AND GENOMICS (2014)
Pharmacogenetic tests: the need for a level playing field
Munir Pirmohamed et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
CYP2D6 Genotype Dependent Oxycodone Metabolism in Postoperative Patients
Ulrike M. Stamer et al.
PLOS ONE (2013)
A Clinical Tool for Reducing Central Nervous System Depression among Neonates Exposed to Codeine through Breast Milk
Lauren E. Kelly et al.
PLOS ONE (2013)
Putative Association of ABCB1 2677G>T/A With Oxycodone-Induced Central Nervous System Depression in Breastfeeding Mothers
Jessica Lam et al.
THERAPEUTIC DRUG MONITORING (2013)
Prediction of Codeine Toxicity in Infants and Their Mothers Using a Novel Combination of Maternal Genetic Markers
J. Sistonen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Pharmacogenomics Knowledge for Personalized Medicine
M. Whirl-Carrillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
Trine Naalsund Andreassen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
More Codeine Fatalities After Tonsillectomy in North American Children
Lauren E. Kelly et al.
PEDIATRICS (2012)
Pupillometry in healthy volunteers as a biomarker of tramadol efficacy
O. Matouskova et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2011)
CYP2D6 Polymorphisms and Codeine Analgesia in Postpartum Pain Management: A Pilot Study
Sondra vanderVaart et al.
THERAPEUTIC DRUG MONITORING (2011)
Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia
S. T. Zwisler et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2010)
Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety
C. F. Samer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The Hypoalgesic Effect of Oxycodone in Human Experimental Pain Models in Relation to the CYP2D6 Oxidation Polymorphism
Stine T. Zwisler et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case-Control Study
P. Madadi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Codeine, Ultrarapid-Metabolism Genotype, and Postoperative Death
Catherine Ciszkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Codeine and morphine pathway
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2009)
Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication
Ulrike M. Stamer et al.
ANESTHESIA AND ANALGESIA (2008)
Pharmacogenetics: From bench to byte
J. J. Swen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Translating pharmacogenomics: Challenges on the road to the clinic
Jesse J. Swen et al.
PLOS MEDICINE (2007)
Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping
D. Frank et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
The effects of tramadol on static and dynamic pupillometry in healthy subjects-the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status
F Fliegert et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Codeine intoxication associated with ultrarapid CYP2D6 metabolism
Y Gasche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Impact of CYP2D6 genotype on postoperative tramadol analgesia
UM Stamer et al.
PAIN (2003)
Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers
J de Leon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability
DG Williams et al.
BRITISH JOURNAL OF ANAESTHESIA (2002)
分享论文
